The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis
Viruses · 20.09.2023 · 15 (9) · 1958
DOI: 10.3390/v15091958 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Viruses, online erschienen am 20.09.2023. Verfasst von Marcos Jessé Abrahão Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Master Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, HIV-1, HIV Infections, HIV Seropositivity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Genetic polymorphisms in genes that encode natural ligands of CCR5 (the main human HIV coreceptor), such as CCL5/RANTES, can alter the levels of secretion of these peptides. This article sought to review the relationship between single nucleotide polymorphisms (SNPs) of CCL5/RANTES and HIV-1 disease susceptibility. A meta-analysis was conducted through 17 articles found from January 1999 to December 2022 in the PUBMED, Science Direct, Medline, and SciELO databases. A total of three SNPs were identified and investigated under their dominant genotypic model and through a fixed-effects model. In terms of the SNP rs2107538 (G > A), in Africa and Asia, it has a protective role (OR = 0.56; 95% CI = 0.41–0.76; p = 0.0002, and OR = 0.88; 95% CI = 0.76–1.02; p = 0.08, respectively). In terms of the SNP rs2280788 (C > G), in Europe and America, it shows a higher risk role (OR = 1.92; 95% CI = 1.06–3.47; p = 0.03, and OR = 0.94; 95% CI = 0.94–1.11; p = 0.04, respectively), but in the population of Asia, with its mutant allele, it has a protective role (OR = 0.76; 95% CI = 0.63–0.93; p = 0.007). In terms of the SNP rs2280789 (T > C), no significant associations were found. Both SNPs rs2107538 and rs2280788 have a positive transcriptional effect on the RANTES/CCL5 gene, while SNP rs2280789 causes a decrease in gene expression levels. This study suggests that there is an association between the increased expression of CCL5/RANTES and a lower risk of AIDS. Therefore, further studies are needed to arrive at a definitive conclusion, and these results may help establish scientific bases for effective HIV/AIDS control strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Master Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil.
- Bacteriology and Mycology Section of the Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil.
- Master and PhD Program in Parasitic Biology in the Amazon (PPGBPA), Department of Natural Science (DCNA/UEPA), University of Pará State (UEPA), Belém 66087-662, PA, Brazil.
- Department of Natural Science (DCNA/UEPA), University of Pará State (UEPA), Belém 66050-540, PA, Brazil.
ORCID-Profile: Yan Corrêa Rodrigues
Zitieren
APA
Silva, M. J. A., Marinho, R. L., Dos Santos, P. A. S., Dos Santos, C. S., Ribeiro, L. R., Rodrigues, Y. C., Lima, K. V. B., & Lima, L. N. G. C. (2023). The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis. Viruses, 15(9), 1958. https://doi.org/10.3390/v15091958
Vancouver
Silva MJA, Marinho RL, Dos Santos PAS, Dos Santos CS, Ribeiro LR, Rodrigues YC, et al. The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis. Viruses. 2023;15(9):1958. doi:10.3390/v15091958
BibTeX
@article{Silva2023,
author = {Silva, Marcos Jessé Abrahão and Marinho, Rebecca Lobato and Dos Santos, Pabllo Antonny Silva and Dos Santos, Carolynne Silva and Ribeiro, Layana Rufino and Rodrigues, Yan Corrêa and Lima, Karla Valéria Batista and Lima, Luana Nepomuceno Gondim Costa},
title = {The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis},
journal = {Viruses},
year = {2023},
volume = {15},
number = {9},
pages = {1958},
doi = {10.3390/v15091958}
}
EUVIMED